These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16755929)

  • 1. [Construction, expression and preliminary pharmacokinetic analysis of IL-1ra mutants].
    Wang YX; Yang ZX; Zhu HQ; Zhou XW; Huang PT
    Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):472-6. PubMed ID: 16755929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Production and One-Step Purification of IL-1Ra in Escherichia coli and Evaluation of its IL-1 Antagonizing Efficacy.
    Adelnia R; Shafiee F
    Iran J Immunol; 2021 Jun; 18(2):141-149. PubMed ID: 34190695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the autoinduction expression system and one-step purification for high-level expression and purification of gallbladder-derived rhIL-1Ra.
    Bashir H; Ahmed N; Khan MA; Zafar AU; Tahir S; Kanwal H; Khan F; Rahman ZU; Husnain T
    Biotechnol Appl Biochem; 2017 Jan; 64(1):20-26. PubMed ID: 26620912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cloning, expression and identification of IL-1ra-Fcepsilon fusion gene].
    Liu Z; Zou M; Wang Y; Wang J; Xu D
    Sheng Wu Gong Cheng Xue Bao; 2008 Oct; 24(10):1754-60. PubMed ID: 19149188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy].
    Fiocco U; Vezzù M; Cozzi L; Todesco S
    Reumatismo; 2004; 56(1 Suppl 1):62-73. PubMed ID: 15201942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system.
    Mahmoudi Azar L; Karaman E; Beyaz B; Göktan I; Eyüpoğlu AE; Kizilel S; Erman B; Gül A; Uysal S
    BMC Biotechnol; 2023 Jun; 23(1):15. PubMed ID: 37340430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of interleukin-1 receptor antagonist mutants with enhanced antagonistic activity in vitro and improved therapeutic efficacy in collagen-induced arthritis.
    Dahlén E; Barchan K; Herrlander D; Höjman P; Karlsson M; Ljung L; Andersson M; Bäckman E; Hager AC; Walse B; Joosten L; van den Berg W
    J Immunotoxicol; 2008 Apr; 5(2):189-99. PubMed ID: 18569390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterization of human glycosylated interleukin-1 receptor antagonist in Pichia pastoris.
    Hamilton BS; Brede Y; Tolbert TJ
    Protein Expr Purif; 2008 May; 59(1):64-8. PubMed ID: 18272394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist].
    Li S; Deng X; Zhao H; Huang X; Yu T; Cheng Y; Dan G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1128-32. PubMed ID: 18027711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.
    Ju G; Labriola-Tompkins E; Campen CA; Benjamin WR; Karas J; Plocinski J; Biondi D; Kaffka KL; Kilian PL; Eisenberg SP
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2658-62. PubMed ID: 1826365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prospect of treating rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
    Bresnihan B
    BioDrugs; 2001; 15(2):87-97. PubMed ID: 11437678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB203580 enhances interleukin-1 receptor antagonist gene expression in IFN-gamma-stimulated BV2 microglial cells through a composite nuclear factor-kappaB/PU.1 binding site.
    Park JS; Jung SH; Seo H; Kim HS
    Neurosci Lett; 2007 Apr; 416(2):169-74. PubMed ID: 17316994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic.
    Shamji MF; Betre H; Kraus VB; Chen J; Chilkoti A; Pichika R; Masuda K; Setton LA
    Arthritis Rheum; 2007 Nov; 56(11):3650-61. PubMed ID: 17968946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cloning of hIL-1Ra gene and its expression in E.coli].
    Chang SH; Wu J; Gong X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):484-7. PubMed ID: 15207099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
    Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
    BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human interleukin-1 receptor antagonist treatment protects rats from myocardial ischemia-reperfusion injury.
    Zhu J; Huang J; Dai D; Wang X; Gao J; Han W; Zhang R
    Biomed Pharmacother; 2019 Mar; 111():1-5. PubMed ID: 30551029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of IL-1Ra-HSA fusion protein and analysis of its bioactivity and pharmacokinetics].
    Huang Y; Hu L; Yang YQ; Hu XP; Zhen YS; Liu MY
    Yao Xue Xue Bao; 2012 Sep; 47(9):1210-8. PubMed ID: 23227553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis.
    Bresnihan B
    Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):17-20. PubMed ID: 11357167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 receptor antagonist (IL-1Ra)-Fc ameliorate autoimmune arthritis by regulation of the Th17 cells/Treg balance and arthrogenic cytokine activation.
    Lee SY; Min HK; Lee SH; Shin HJ; Lee WY; Cho YG; Kwok SK; Ju JH; Cho ML; Park SH
    Immunol Lett; 2016 Apr; 172():56-66. PubMed ID: 26903194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney as a major clearance organ for recombinant human interleukin-1 receptor antagonist.
    Kim DC; Reitz B; Carmichael DF; Bloedow DC
    J Pharm Sci; 1995 May; 84(5):575-80. PubMed ID: 7658347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.